Back to Results
First PageMeta Content
Enzyme inhibitor / Medicinal chemistry / Metabolism


Genkyotex Raises CHF 20 Million ($21 Million) Company funded through Phase 2 results and to expand pipeline Geneva, Switzerland, and Archamps, France, 7 January 2015 – Genkyotex, the leading developer of selective NOX
Add to Reading List

Document Date: 2015-01-07 03:17:26


Open Document

File Size: 84,05 KB

Share Result on Facebook